{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:30:36Z","timestamp":1782513036464,"version":"3.54.5"},"reference-count":85,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:p>\n                    Current prescribing practices for venous thromboembolism (\n                    <jats:styled-content style=\"fixed-case\">VTE<\/jats:styled-content>\n                    ) prophylaxis and treatment are suboptimal, particularly regarding the use of appropriate prophylaxis in accordance with evidence\u2010based guidelines. Failure to prevent avoidable\n                    <jats:styled-content style=\"fixed-case\">VTE<\/jats:styled-content>\n                    is associated with a substantial clinical and economic burden, due not only to the initial event, but also to\n                    <jats:styled-content style=\"fixed-case\">VTE<\/jats:styled-content>\n                    recurrence and long\u2010term sequelae. Quality improvement initiatives such as the Surgical Care Improvement Project, the Centers for Medicare and Medicaid Services, the National Quality Forum, and The Joint Commission have developed performance measures to address the shortfall and improve adherence with best\u2010practice recommendations. Several studies have highlighted the benefits of pharmacist\u2010led anticoagulation services for reducing the occurrence of\n                    <jats:styled-content style=\"fixed-case\">VTE<\/jats:styled-content>\n                    and bleeding complications while reducing excess hospitalization and health care costs. By assuming responsibility for anticoagulation management, pharmacists can ensure that at\u2010risk patients receive the correct drug at the correct dose for the correct duration, from initial presentation to outpatient follow\u2010up. Increasing continuity of care in this manner will ultimately improve patient outcomes and reduce costs. Pharmacists can also play a key role in helping hospitals achieve performance measures by aiding in the development and implementation of local\n                    <jats:styled-content style=\"fixed-case\">VTE<\/jats:styled-content>\n                    guidelines, policies, and other quality improvement initiatives; by helping to establish critical pathways with protocols; and by providing valuable education for other health care professionals and patients alike. Pharmacists are in an ideal position to facilitate achievement of\n                    <jats:styled-content style=\"fixed-case\">VTE<\/jats:styled-content>\n                    \u2010related performance measures and can thus substantially contribute to the much\u2010needed improvement in current\n                    <jats:styled-content style=\"fixed-case\">VTE<\/jats:styled-content>\n                    prevention and care.\n                  <\/jats:p>","DOI":"10.1002\/phar.1244","type":"journal-article","created":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T08:53:10Z","timestamp":1364806390000},"page":"650-664","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Role of the Pharmacist in Achieving Performance Measures to Improve the Prevention and Treatment of Venous Thromboembolism"],"prefix":"10.1002","volume":"33","author":[{"given":"Paul P.","family":"Dobesh","sequence":"first","affiliation":[{"name":"College of Pharmacy University of Nebraska Medical Center Omaha Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby C.","family":"Trujillo","sequence":"additional","affiliation":[{"name":"University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon W.","family":"Finks","sequence":"additional","affiliation":[{"name":"College of Pharmacy University of Tennessee Health Science Center Memphis Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,4]]},"reference":[{"issue":"1","key":"e_1_2_7_2_1","first-page":"I4","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White RH","year":"2003","journal-title":"Circulation"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2006.05.001"},{"key":"e_1_2_7_4_1","first-page":"101","article-title":"Prevention and treatment of venous thromboembolism: International Consensus Statement","volume":"25","author":"Nicolaides AN","year":"2006","journal-title":"Int Angiol"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.1283"},{"key":"e_1_2_7_6_1","unstructured":"National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology. Venous Thromboembolic Disease V2.2008. Available fromhttp:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/vte.pdf. Accessed June 8 2012."},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2296"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2297"},{"key":"e_1_2_7_9_1","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients","volume":"141","author":"Flack\u2010Ytter Y","year":"2012","journal-title":"Chest"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2007.06.009"},{"key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1160\/TH07-11-0708","article-title":"Preventing venous thromboembolism in U.S. hospitals: are surgical patients receiving appropriate prophylaxis?","volume":"99","author":"Amin AN","year":"2008","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_12_1","doi-asserted-by":"crossref","first-page":"Abstract 1287","DOI":"10.1182\/blood.V112.11.1287.1287","article-title":"Appropriate VTE prophylaxis is associated with lower direct medical costs among medical and surgical patients in the United States","volume":"112","author":"Amin A","year":"2008","journal-title":"Blood"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-009-0361-z"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060390"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60202-0"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.01012.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0430"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2993"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060115"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2006.01.011"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.98.11.507"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.13.1458"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp100543"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.5.621"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.06.009"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-011-0632-3"},{"key":"e_1_2_7_27_1","unstructured":"Surgeon General's Call to Action to prevent deep vein thrombosis and pulmonary embolism. Available fromhttp:\/\/www.surgeongeneral.gov\/library\/calls\/deepvein\/call-to-action-on-dvt-2008.pdf. Accessed August 8 2012."},{"key":"e_1_2_7_28_1","unstructured":"The Joint Commission.Core Measures Sets. Available fromhttp:\/\/www.jointcommission.org\/core_measure_sets.aspx. Accessed August 8 2012."},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.6.809"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.11.1245"},{"key":"e_1_2_7_31_1","volume-title":"Statistical abstract of the United States: 2000","author":"U.S. Bureau of the Census","year":"2000"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.6_suppl.349S"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.132S"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.338S"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/153857440203600506"},{"key":"e_1_2_7_36_1","volume-title":"To err is human: building a safer health system","author":"Kohn KT","year":"1999"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.14.1868"},{"key":"e_1_2_7_38_1","unstructured":"The Joint Commission.Improving America's Hospitals. The Joint Commission's Annual Report on Quality and Safety 2011. Available fromhttp:\/\/www.jointcommission.org\/assets\/1\/6\/TJC_Annual_Report_2011_9_13_11_.pdf. Accessed August 8 2012."},{"key":"e_1_2_7_39_1","unstructured":"The Joint Commission National Patient Safety Goals 2009. Available fromhttp:\/\/www.jointcommission.org\/PatientSafety\/NationalPatientSafetyGoals\/. Accessed August 8 2012."},{"key":"e_1_2_7_40_1","unstructured":"CMS.Hospital\u2010acquired conditions. Available at:http:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/HospitalAcqCond\/index.html?redirect=\/HospitalAcqCond\/. Accessed August 8 2012."},{"key":"e_1_2_7_41_1","unstructured":"Hospital Compare Website. Available at:http:\/\/www.hospitalcompare.hhs.gov\/. Accessed August 8 2012."},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.8.943"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2007.13.6.475"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06200.x"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060388"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032274"},{"key":"e_1_2_7_47_1","first-page":"1082","article-title":"Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a U.S. perspective","volume":"8","author":"Lissovoy G","year":"2002","journal-title":"Am J Manag Care"},{"key":"e_1_2_7_48_1","first-page":"632","article-title":"Cost effectiveness of thromboprophylaxis with a low\u2010molecular\u2010weight heparin versus unfractionated heparin in acutely ill medical inpatients","volume":"10","author":"McGarry LJ","year":"2004","journal-title":"Am J Manag Care"},{"key":"e_1_2_7_49_1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1160\/TH08-04-0248","article-title":"Comparison of the two\u2010year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism","volume":"100","author":"Deitelzweig SB","year":"2008","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_50_1","first-page":"e171","article-title":"A survey of pharmacy and therapeutic committees across Canada: scope and responsibilities","volume":"16","author":"Mittmann N","year":"2009","journal-title":"Can J Clin Pharmacol"},{"key":"e_1_2_7_51_1","first-page":"158","article-title":"Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs","volume":"24","author":"Chiquette E","year":"1998","journal-title":"Arch Intern Med"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18192"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.11.953.36133"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2005.11.9.755"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.5.1515"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20281"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070595"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.7.761"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2007.00792.x"},{"key":"e_1_2_7_60_1","unstructured":"MahanCE HusseinMA AlpeshAN et\u00a0al.Venous Thromboembolism (VTE) Pharmacy Intervention Management Program. Abstract OC\u2010TH\u2010016. Presented at: International Society on Thrombosis and Hemostasis XXIIst Congress; July 11\u201316 2009;Boston MA USA."},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080475"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/59.21.2089"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.17.2014"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.9.955"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070292"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/13561820802602552"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060264"},{"key":"e_1_2_7_68_1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ajhp\/61.9.939","article-title":"ASHP guidelines on the pharmacist's role in the development, implementation, and assessment of critical pathways","volume":"61","author":"ASHP","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.9.1358"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.8.901"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2298"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-006-8328-9"},{"key":"e_1_2_7_73_1","first-page":"70","article-title":"A pilot study of home treatment of deep vein thrombosis with subcutaneous once\u2010daily enoxaparin plus warfarin","volume":"12","author":"Bishop B","year":"2006","journal-title":"J Manag Care Pharm"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1331\/1544345041475751"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.14.1525"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1080\/00016470052943883"},{"key":"e_1_2_7_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20983"},{"key":"e_1_2_7_78_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.14.1471"},{"key":"e_1_2_7_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7933.2004.00588.x"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060234"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060119"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070620"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.5688\/aj700492"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.3821\/1913-701X(2008)141[278:IOAPAC]2.0.CO;2"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/10810730600829874"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0708-8"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fphar.1244","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.1244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:09:59Z","timestamp":1761070199000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.1244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1002\/phar.1244"],"URL":"https:\/\/doi.org\/10.1002\/phar.1244","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"2013-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}